Arthritis induced by cancer therapy may persist after stopping treatment

Inflammatory arthritis caused by immune checkpoint inhibitor drugs can become a long-term problem, but it can be treated. Introduction Immune checkpoint inhibitors are a type of immunotherapy used to treat cancer. There are several drugs in this group, and they are used in more than 10 cancer types. This type of treatment for cancer is […]

Read More…

The role of the nurse in inflammatory arthritis

This is the lay version of the updated EULAR recommendations for the role of the nurse in managing chronic inflammatory arthritis. The original publication can be downloaded from the EULAR website: www.eular.org. Bech B, et al. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. […]

Read More…

Physical activity

This is the lay version of the EULAR recommendations for physical activity in people with inflammatory arthritis or osteoarthritis. The original publication can be downloaded from the EULAR website: www.eular.org. Rausch Osthoff AK, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2018;77:1251–1260 doi:10.1136/annrheumdis-2018-213585 Introduction EULAR […]

Read More…

Cancer drugs may trigger inflammatory arthritis

Immune checkpoint inhibitors may trigger the development of rheumatoid arthritis or polymyalgia rheumatica in some patients, but it can be treated. INTRODUCTION Inflammatory arthritis develops when the immune system starts to attack the body’s own tissues. Inflammatory arthritis is an umbrella term for a group of chronic inflammatory diseases that affect a person’s joints, causing […]

Read More…

Vaccination for people with autoimmune inflammatory rheumatic diseases

Introduction Vaccinations are a way of preventing infections before they happen. Vaccines help the immune system to recognise viruses and bacteria that cause disease. Recommendations give advice to doctors and patients about the best way to treat and manage diseases. EULAR published in 2011 the current recommendations on vaccination for people with autoimmune inflammatory rheumatic […]

Read More…

Education for people with inflammatory arthritis

INTRODUCTION Patient education is a planned interactive learning process designed to support and enable people with inflammatory arthritis to manage their life and optimise their health. Patient education activities include giving help and advice on healthy living and how to stay well. Receiving patient education helps people to manage their own illness and to have […]

Read More…

Continuous NSAID offers no benefit over on-demand in ankylosing spondylitis

More evidence is needed to confirm whether continuous NSAID can reduce joint damage in people with ankylosing spondylitis. INTRODUCTION Ankylosing spondylitis is a chronic inflammatory disease. It mainly involves the joints, but may be associated with other diseases, such as psoriasis (a skin disease), inflammatory bowel disease and uveitis (an inflammation in the eye). These […]

Read More…

Tofacitinib effective despite previous biologic therapy

Tofacitinib is effective in reducing the signs and symptoms of rheumatoid arthritis when used either before or after biologics. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common in older people, but there is also a […]

Read More…

Do patients prefer nurse specialists to manage their DMARD treatment?

INTRODUCTION People taking disease-modifying antirheumatic drugs (DMARDs) for inflammatory arthritis are more likely to be satisfied with their care if they have follow-up appointments with a clinical nurse specialist, rather than with a doctor, a study shows. WHAT DO WE KNOW ALREADY? ‘Inflammatory arthritis’ is an umbrella term that covers several conditions, including rheumatoid arthritis, ankylosing spondylitis, […]

Read More…